Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Katrine Risager Christensen"'
Autor:
Lene Dreyer, Lars Erik Kristensen, Mark Andrew Ainsworth, Tanja Schjødt Jørgensen, Simon Francis Thomsen, Katrine Risager Christensen, Marie Skougaard, Zara R Stisen, Rebekka Lund Hansen, Mette Mogensen
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Objectives Exploring patients’ perspectives for significant factors of relevance in living with a chronic disease is important to discover unmet needs and challenges. The primary objective of this study was to explore disease-related and treatment-
Externí odkaz:
https://doaj.org/article/877f7b18b4904b2ea1793f09a05ad214
Autor:
Casper Steenholdt, Lars Erik Kristensen, Mark Andrew Ainsworth, Tanja Schjødt Jørgensen, Jørn Brynskov, Katrine Risager Christensen, Marie Skougaard, Sine Buhl
Publikováno v:
BMJ Open Gastroenterology, Vol 9, Iss 1 (2022)
Objective Physicians tend to focus on biomedical targets while little is known about issues important to patients. We aimed to identify critical concepts impacting patients with inflammatory bowel disease (IBD).Design We performed a survey of patient
Externí odkaz:
https://doaj.org/article/afabc5e02f694f9091f6a98c98a4869c
Autor:
John Gásdal Karstensen, Katrine Risager Christensen, Jørn Brynskov, Claus Rønholt, Peter Vilmann, Jakob Hendel
Publikováno v:
Endoscopy International Open, Vol 04, Iss 03, Pp E296-E300 (2016)
Background and study aims: In patients with Crohn’s disease, the idea of biodegradable stents for treatment of bowel strictures with limited effect of endoscopic balloon dilation is tempting and initial results have been promising. The aim of this
Externí odkaz:
https://doaj.org/article/fd3bbd8f92464a61a35cf0ccf2bf7c12
Autor:
Sine Buhl, Casper Steenholdt, Jørn Brynskov, Katrine Risager Christensen, Maria Dorn-Rasmussen, Ole Østergaard Thomsen, Klaus Bendtzen, Tobias Wirenfeldt Klausen, Jens Frederik Dahlerup, Niels Thorsgaard, Jørgen Jahnsen, Akbar Molazahi, Natalia Pedersen, Jens Kjeldsen, Sven Almer, Eva Efsen Dahl, Ida Vind, Annett Gerhardt Cannon, Jan Marsal, Taina Sipponen, Jørgen Steen Agnholt, Hendrika Adriana Linda Kievit, Synnøve Louise Aure, Lars Martinsen, Svetlana Meisner, Jane Møller Hansen, Mark Andrew Ainsworth
Publikováno v:
NEJM Evidence. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45f57c30f6970e2832e23c1a8454a7d1
https://doi.org/10.1056/evidoa2200061
https://doi.org/10.1056/evidoa2200061
Autor:
Katrine Risager Christensen, Mark Andrew Ainsworth, Marie Skougaard, Casper Steenholdt, Sine Buhl, Jørn Brynskov, Lars Erik Kristensen, Tanja Schjødt Jørgensen
Background: Physicians tend to focus on biomedical targets (endoscopic remission), while little is known about issues important to patients. We aimed to identify critical concepts impacting inflammatory bowel disease (IBD) patients.Methods: We perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17cbcd55e95fd03c2998b777cc73d39c
https://doi.org/10.21203/rs.3.rs-1442214/v1
https://doi.org/10.21203/rs.3.rs-1442214/v1
Publikováno v:
Christensen, K R, Steenholdt, C, Buhl, S, Brynskov, J & Ainsworth, M A 2022, ' A systematic monitoring approach to biologic therapies in inflammatory bowel disease : patients’ and physicians’ preferences and adherence ', Scandinavian Journal of Gastroenterology, vol. 57, no. 3, pp. 274-281 . https://doi.org/10.1080/00365521.2021.2002397
Objectives: Treatment of patients with inflammatory bowel disease (IBD) should aim at achieving mucosal healing. However, monitoring schedules to support this goal remain undefined. We aimed to identify patients’ and physicians’ preferences regar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3976d247ac4e99a4167e30078e74f757
https://portal.findresearcher.sdu.dk/da/publications/9aa89893-c65f-4252-a934-6a932bf76dd5
https://portal.findresearcher.sdu.dk/da/publications/9aa89893-c65f-4252-a934-6a932bf76dd5
Autor:
Katrine Risager Christensen, Mark Andrew Ainsworth, Casper Steenholdt, Sine Buhl, Marie Skougaard, Jørn Brynskov, Tanja Schjødt Jørgensen, Lars Erik Kristensen
Fatigue is a common symptom reported by patients with chronic immunoinflammatory diseases and with profound negative implications on health-related quality of life. This study aimed to delineate underlying components contributing to fatigue in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e725fb971c15b9a718dbbc5f2c81111
Autor:
Katrine Risager Christensen, Mark Andrew Ainsworth, Marie Skougaard, Casper Steenholdt, Sine Buhl, Jørn Brynskov, Lars Erik Kristensen, Tanja Schjødt Jørgensen
Publikováno v:
Christensen, K R, Ainsworth, M A, Skougaard, M, Steenholdt, C, Buhl, S, Brynskov, J, Kristensen, L E & Jørgensen, T S 2022, ' Identifying and understanding disease burden in patients with inflammatory bowel disease ', BMJ Open Gastroenterology, vol. 9, no. 1, 000994 . https://doi.org/10.1136/bmjgast-2022-000994
ObjectivePhysicians tend to focus on biomedical targets while little is known about issues important to patients. We aimed to identify critical concepts impacting patients with inflammatory bowel disease (IBD).DesignWe performed a survey of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aec8843850fa6cff600e0919881ff63e
https://doi.org/10.1136/bmjgast-2022-000994
https://doi.org/10.1136/bmjgast-2022-000994
Autor:
Katrine Risager Christensen, Jakob Hendel, Jørn Brynskov, Peter Vilmann, John Gásdal Karstensen, Claus Rønholt
Publikováno v:
Endoscopy International Open, Vol 04, Iss 03, Pp E296-E300 (2016)
Endoscopy International Open
Endoscopy International Open
Background and study aims: In patients with Crohn’s disease, the idea of biodegradable stents for treatment of bowel strictures with limited effect of endoscopic balloon dilation is tempting and initial results have been promising. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52666db54f35bf5e74ac0a080e1f489f
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-101940
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-101940
Publikováno v:
Ugeskrift for laeger. 176(48)
Treatment of inflammatory bowel disease with anti-tumour necrosis factor (TNF)-alpha biopharmaceuticals is generally well tolerated, but increases the risk of infections due to globally induced suppression of the immune system. National and internati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee206d14370a836b801ec03c6b86fdd5
https://pubmed.ncbi.nlm.nih.gov/25430572
https://pubmed.ncbi.nlm.nih.gov/25430572